Last reviewed · How we verify
NCT03474367
Cost-effectiveness of Urgent-start Therapies Hemodialysis and Peritoneal Dialysis
trial in Cost-effectiveness Analysis in 198 participants. Status unknown.
12 March 2020
Quick facts
| Lead sponsor | Universidade Estadual Paulista Júlio de Mesquita Filho |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 198 |
| Start date | 1 April 2017 |
| Primary completion | 12 March 2020 |
| Estimated completion | 12 December 2021 |
| Sites | 1 location across Brazil |
Conditions studied
- Cost-effectiveness Analysis — all drugs for Cost-effectiveness Analysis →
- Chronic Kidney Disease Requiring Chronic Dialysis — all drugs for Chronic Kidney Disease Requiring Chronic Dialysis →
Sponsor
Universidade Estadual Paulista Júlio de Mesquita Filho — full company profile →
Who can join
18 and older, any sex, with Cost-effectiveness Analysis or Chronic Kidney Disease Requiring Chronic Dialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the cost-effectiveness of unplanned dialysis (peritoneal dialysis and hemodialysis) in chronic kidney disease (CKD) during the first year of therapy in a single center.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.
Htay H, Johnson DW, Craig JC, Teixeira-Pinto A, et al · · 2021 · cited 23× · PMID 33501650 · DOI 10.1002/14651858.cd012899.pub2 -
Urgent-start peritoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidney disease.
Htay H, Johnson DW, Craig JC, Teixeira-Pinto A, et al · · 2020 · cited 16× · PMID 33320346 · DOI 10.1002/14651858.cd012913.pub2
Verify or expand the search:
- PubMed search for NCT03474367
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cost-effectiveness Analysis
Currently open trials in the same condition.
- NCT06887699 — The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value- · NA · recruiting
- NCT06278974 — Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K · recruiting
- NCT06388278 — Cost-effectiveness Analysis of an Antimicrobial Stewardship Program in Regione Lombardia (RF-net2018) · recruiting
Other Universidade Estadual Paulista Júlio de Mesquita Filho trials
Trials by the same sponsor.
- NCT07131748 — Effect of Heated Water-Based Versus Land-Based Exercise Training on Hemodynamic Variables, Functional Capacity and Quali · NA · recruiting
- NCT07113444 — Acute Effect of Tai Chi Versus Moderate-Intensity Combined Exercise on Cardiovascular, Metabolic, and Cardiac Autonomic · NA · not yet recruiting
- NCT07131761 — Effect of Tai Chi Versus Moderate-intensity Combined Exercise Training on Cardiovascular Health and Physical Functional · NA · not yet recruiting
- NCT06405477 — EFFECTS OF L-ARGININE SUPPLEMENTATION ON THE RECOVERY OF CARDIORESPIRATORY PARAMETERS AFTER SUBMAXIMAL EXERCISE TEST · NA · recruiting
- NCT06248164 — Relationship of Lifestyle Habits and Health Characteristics of Parents and Children · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03474367 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Estadual Paulista Júlio de Mesquita Filho
- Last refreshed: 2 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03474367.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing